PCI Acquires Biotec

September 19, 2014
BioPharm International Editors

PCI's acquisition of Biotech Services International expands the packaging services provider's presence in Europe.

PCI, a provider of packaging services, has acquired Biotec Services International, a provider of clinical trial services and temperature controlled pharmaceutical services headquartered in Bridgend, Wales, UK.  The addition expands PCI’s presence in the United Kingdom/European Union to support global investigational studies of medicinal products by adding packaging, storage, and distribution capacity, and consultative services for clinical trial supplies, the company reports.

Biotec supports global projects across a range of temperature conditions including controlled room temperature. A Recent facilities expansion quadrupled the company’s capacity to store, package and ship cold chain products, and includes a second purpose-built facility for the storage of advanced therapeutic medicinal products including include gene therapies, somatic cell therapies (stem cells) and tissue engineered products.

In August, PCI acquired Penn Pharma, adding pharmaceutical development and contained manufacturing services to its portfolio of clinical trial services, commercial packaging, and laboratory services. 

Source: PCI